View this email in your browser

Coronavirus causes financial crisis for hospitals and doctors – Patients lose vital care
Fox News | Sally C. Pipes
May 11, 2020

Americans adapted quickly to this new reality. Doctor visits declined nearly 60 percent from March to April – a stunning amount, according to a new Commonwealth Fund study. Some of the largest drop-offs occurred in surgery and pediatric care. Telehealth visits increased slightly, but not enough to offset the overall drop in care.


The Savings Potential Of Biosimilars Is More Urgent Than Ever
Forbes.com | Wayne Winegarden
May 7, 2020

When people worry about the cost of medicines, they are, either knowingly or unknowingly, worrying about biologic medicines. In fact, most prescriptions are affordable. Consider that the vast majority of drugs (90%) are generics, and the vast majority of these medicines (95%) cost patients $20 or less.
Register for PRI "Medicare for All and the COVID-19 Crisis with Sally C. Pipes" Webinar on May 20 at 11 AM PST.


COVID-19 Makes Employer-Based Coverage Indefensible
Forbes | Sally C. Pipes
May 12, 2020

The employer-sponsored model has also inflated U.S. health spending. Individuals don’t perceive the true cost of the care they consume. After all, the average employer picks up more than 80% of individual plan premiums, and 70% of family premiums.


Finding Solace In The Time Of COVID-19
Issues & Insights | Henry Miller, M.S., M.D. and Mia Zaharna
May 7, 2020

The researchers believe that this is how a person can control breathing in order to shift consciousness from an aroused or even agitated state to a more meditative one, a basic aspect of virtually all varieties of yoga and related disciplines, including mindfulness.

The PRI Center for Medical Economics and Innovation released the fourth video in its series about explaining drug innovation costs. Watch Professor Salvare take Pete Paystoomuch observe the government, the private sector, universities, and foundations pass the baton in a research relay race that is ultimately anchored by private companies who finish the race to develop new medicines that treat illnesses and create cures for devastating diseases.
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104



Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.